Jun 22, 2020
Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries
Jun 22, 2020
Sutro Biopharma Presents New Preclinical Data at 2020 AACR Virtual Annual Meeting II Suggesting Synergy between its STRO-002 Antibody-Drug Conjugate and Immune Checkpoint Inhibitors Resulting in Tumor Regression and Adaptive Anti-Tumor Immunity
Jun 17, 2020
Leukemia Therapeutics Markets, 2015-2025 - Size by Value & Volume, Trends & Developments, Competitive Landscape
Jun 16, 2020
CAR-T Therapy Market Outlook to 2030 by Target Antigen, Application, Region, Country and Company
Jun 10, 2020
Biohaven Appoints Bob Hugin to its Board of Directors
Jun 09, 2020
Sutro Biopharma to Present New Preclinical Data on its STRO-002 Antibody-Drug Conjugate at the Upcoming AACR 2020 Virtual Meeting on June 22, 2020
Jun 02, 2020
The Global Psoriasis Therapeutics Market is expected to grow from USD 14,236.13 Million in 2018 to USD 26,125.13 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 9.06%
May 21, 2020
Sutro Biopharma Expands Senior Management with the Additions of Vice President of Clinical Development and Vice President of Finance and Controller
May 11, 2020
Sutro Biopharma Announces Pricing of $85.3 Million Public Offering
May 11, 2020
Sutro Biopharma Announces Proposed Public Offering
May 11, 2020
Sutro Biopharma Reports First Quarter 2020 Financial Results and Recent Business Highlights and Developments
Apr 22, 2020
World Orphan Drugs Industry Overview 2020: Valued at $132.6 Billion in 2019
Apr 21, 2020
Multiple Sclerosis Drugs Industry Assessment 2020: Immunomodulators, Immunosuppressants, Interferons and Others
Apr 17, 2020
Visiongain Report: The Gene Therapy Market is Projected to Grow at a CAGR of 32% in the First Half of the Forecast Period
Apr 14, 2020
Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma
Apr 14, 2020
Worldwide Licensing Partnering Deals in Pharma, Biotech & Diagnostics, 2014-2020
Apr 13, 2020
Sutro Biopharma to Present Updated Clinical Data for its STRO-002 Antibody-Drug Conjugate at the AACR Virtual Annual Meeting on April 27, 2020
Apr 13, 2020
Antengene Corporation Appoints Former Celgene ANZ General Manager Thomas Karalis as Head of Asia Pacific Regions
Apr 09, 2020
Co-development Partnering Terms & Agreements in Global Pharma, Biotech & Diagnostics Sectors 2014-2020: Key Trends, Players and Financials
Apr 09, 2020
Global Pharma, Biotech & Diagnostics Co-promotion & Co-marketing Partnering Terms & Agreements Report, 2014-2020